Tomáš Zábranský

865 total citations
22 papers, 337 citations indexed

About

Tomáš Zábranský is a scholar working on Epidemiology, Toxicology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Tomáš Zábranský has authored 22 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 6 papers in Toxicology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Tomáš Zábranský's work include HIV, Drug Use, Sexual Risk (12 papers), Substance Abuse Treatment and Outcomes (8 papers) and Forensic Toxicology and Drug Analysis (6 papers). Tomáš Zábranský is often cited by papers focused on HIV, Drug Use, Sexual Risk (12 papers), Substance Abuse Treatment and Outcomes (8 papers) and Forensic Toxicology and Drug Analysis (6 papers). Tomáš Zábranský collaborates with scholars based in Czechia, United States and Georgia. Tomáš Zábranský's co-authors include Jessica Singleton, Wayne Hall, Louisa Degenhardt, Vendula Běláčková, Viktor Mravčík, M. Suresh Kumar, David L. Thomas, Jean‐Paul Grund, Irma Kirtadze and David Otiashvili and has published in prestigious journals such as Addiction, Drug and Alcohol Dependence and Journal of Substance Abuse Treatment.

In The Last Decade

Tomáš Zábranský

18 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomáš Zábranský Czechia 11 229 89 81 57 49 22 337
Viktor Mravčík Czechia 13 263 1.1× 145 1.6× 56 0.7× 59 1.0× 97 2.0× 61 479
Kerryn Butler Australia 12 190 0.8× 68 0.8× 40 0.5× 88 1.5× 91 1.9× 17 319
James Fetherston Australia 9 271 1.2× 170 1.9× 89 1.1× 88 1.5× 19 0.4× 13 424
Bridie O'Reilly Australia 8 208 0.9× 114 1.3× 103 1.3× 54 0.9× 16 0.3× 13 397
G.H.A. van Brussel Netherlands 11 257 1.1× 198 2.2× 41 0.5× 49 0.9× 20 0.4× 15 387
David Otiashvili United States 12 297 1.3× 161 1.8× 33 0.4× 33 0.6× 27 0.6× 43 410
Natasha Sindicich Australia 10 162 0.7× 88 1.0× 43 0.5× 73 1.3× 13 0.3× 16 329
Nelson Arruda Canada 13 422 1.8× 292 3.3× 111 1.4× 85 1.5× 106 2.2× 22 558
Peter Lawrinson Australia 7 243 1.1× 150 1.7× 34 0.4× 21 0.4× 15 0.3× 7 346
Paige Webb Australia 6 214 0.9× 86 1.0× 21 0.3× 23 0.4× 70 1.4× 13 308

Countries citing papers authored by Tomáš Zábranský

Since Specialization
Citations

This map shows the geographic impact of Tomáš Zábranský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Zábranský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Zábranský more than expected).

Fields of papers citing papers by Tomáš Zábranský

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomáš Zábranský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Zábranský. The network helps show where Tomáš Zábranský may publish in the future.

Co-authorship network of co-authors of Tomáš Zábranský

This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Zábranský. A scholar is included among the top collaborators of Tomáš Zábranský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Zábranský. Tomáš Zábranský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mravčík, Viktor, et al.. (2020). Prevalence of high-risk drug use and coverage of opioid substitution treatment and needle and syringe programs in Lithuania in 2015–2016: A multi-method estimation study. Journal of Substance Abuse Treatment. 122. 108229–108229. 3 indexed citations
2.
Kirtadze, Irma, et al.. (2018). Republic of Georgia estimates for prevalence of drug use: Randomized response techniques suggest under-estimation. Drug and Alcohol Dependence. 187. 300–304. 9 indexed citations
3.
Běláčková, Vendula, et al.. (2017). “Just another drug” for marginalized users: The risks of using synthetic cathinones among NSP clients in the Czech Republic. Journal of Substance Use. 22(6). 567–573. 5 indexed citations
4.
Běláčková, Vendula, et al.. (2016). Qualitative research in Spanish cannabis social clubs: “The moment you enter the door, you are minimising the risks”. International Journal of Drug Policy. 34. 49–57. 34 indexed citations
5.
Zábranský, Tomáš. (2015). On a search for useful indicators… or not?. Addiction. 110(5). 741–743. 1 indexed citations
6.
Mravčík, Viktor, et al.. (2015). [New psychoactive substances and their prevalence in the Czech Republic].. PubMed. 154(5). 216–21. 1 indexed citations
7.
Mravčík, Viktor, et al.. (2014). Mortality of registered drug users in Central Asia. International Journal of Drug Policy. 25(6). 1215–1220. 8 indexed citations
8.
Zábranský, Tomáš, et al.. (2014). Post-Soviet Central Asia: A summary of the drug situation. International Journal of Drug Policy. 25(6). 1186–1194. 18 indexed citations
9.
10.
Mravčík, Viktor, et al.. (2011). Use of gelatine capsules for application of methamphetamine: A new harm reduction approach. International Journal of Drug Policy. 22(2). 172–173. 12 indexed citations
11.
Zábranský, Tomáš, et al.. (2011). Mortality of Cohort of Very Young Injecting Drug Users in Prague, 1996-2010. Central European Journal of Public Health. 19(3). 152–157. 10 indexed citations
12.
Thomas, David L., et al.. (2011). Hepatitis C in HIV‐infected individuals: cure and control, right now. Journal of the International AIDS Society. 14(1). 22–22. 37 indexed citations
13.
Mravčík, Viktor, et al.. (2010). [Ethanol and other psychoactive substances in fatal road traffic accidents in the Czech Republic in 2008].. PubMed. 149(7). 332–6.
14.
Singleton, Jessica, Louisa Degenhardt, Wayne Hall, & Tomáš Zábranský. (2009). Mortality among amphetamine users: A systematic review of cohort studies. Drug and Alcohol Dependence. 105(1-2). 1–8. 78 indexed citations
15.
Otiashvili, David, et al.. (2009). Why Do the Clients of Georgian Needle Exchange Programmes Inject Buprenorphine?. European Addiction Research. 16(1). 1–8. 24 indexed citations
16.
Grund, Jean‐Paul, et al.. (2009). Stimulant Use in Central and Eastern Europe. 3 indexed citations
17.
Mravčík, Viktor, et al.. (2007). Drugs and Fatal Traffic Accidents in the Czech Republic. Central European Journal of Public Health. 15(4). 158–162. 8 indexed citations
18.
Zábranský, Tomáš, et al.. (2006). Hepatitis C Virus Infection among Injecting Drug Users in the Czech Republic – Prevalence and Associated Factors. European Addiction Research. 12(3). 151–160. 12 indexed citations
19.
Mravčík, Viktor, et al.. (2005). [Drugs and traffic accidents].. PubMed. 144(8). 550–5; discussion 555. 2 indexed citations
20.
Zábranský, Tomáš. (2004). Czech Drug Laws as an Arena of Drug Policy Battle. Journal of Drug Issues. 34(3). 661–686. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Viktor Mravčík Breakdown of academic impact, for papers by Kerryn Butler Breakdown of academic impact, for papers by James Fetherston Breakdown of academic impact, for papers by Bridie O'Reilly Breakdown of academic impact, for papers by G.H.A. van Brussel Breakdown of academic impact, for papers by David Otiashvili Breakdown of academic impact, for papers by Natasha Sindicich Breakdown of academic impact, for papers by Nelson Arruda Breakdown of academic impact, for papers by Peter Lawrinson Breakdown of academic impact, for papers by Paige Webb
Rankless by CCL
2026